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Accepted 1 February 2011AbstractObjective: Because pregnancy suppresses the immune system, women at any stage of pregnancy are more susceptible to bacterial and viral
infection. Pregnant women might thus be at increased risk of complications from pandemic H1N1 virus infection, and illness may progress rapidly.
Case Report: A 23-year-old primigravida at 9 weeks’ gestation was presented to our institution because of the sudden onset of sore throat, fever,
chills, and vomiting for 5 days. She was diagnosed with early pregnancy H1N1 infection, vulvar herpes infection, and impending intravascular
disseminated coagulopathy. Oseltamivir (Tamiflu) 75 mg and valacyclovir 500 mg were then administered orally twice daily for 5 days. The
patient’s fever, chills, and vomiting subsided 2 days later. The real-time reverse-transcriptase polymerase chain reaction (RT-PCR) analysis of
nasal discharge for influenza virus types A and B showed positive results for the A/H1N1 influenza virus. The early pregnancy was terminated by
therapeutic curettage at the patient’s request. The surgical specimen revealed products of conception with the presence of necrotic chorionic villi,
and focal lymphocytes in decidual tissue. RT-PCR analysis of gestational tissue for A/H1N1 was negative.
Conclusion: Pregnant women with H1N1 infection seem to benefit from antiviral therapy.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Influenza A virus is an RNA, single-stranded, enveloped,
orthomyxovirus that contains H and N surface glycoproteins.
The Center for Disease Control and Prevention (CDC) first
identified cases of respiratory infection with the 2009 H1N1
influenza virus in the United States in April 2009. On July 11,
the 2009 H1N1 influenza virus spread was considered
pandemic. Identification of this virus in humans attracted
attention because the viral gene segment is a triple-reassortant
derived from avian, human, and swine lineages [1]. According
to the literature, pregnant women are at high risk of compli-
cations from influenza. The rate of hospital admission for* Corresponding author. Department of Obstetrics and Gynecology, Kuo
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women [2]. In addition, adverse pregnancy outcomes have
been reported following previous influenza pandemics, with
increased rates of spontaneous abortion and preterm birth [3].
Herein, we present a case of severe complicated 2009 H1N1
influenza virus infection in a woman in early pregnancy.
Case report
A 23-year-old woman, gravida 1, para 0, was presented to our
institution in October 2009 because of the sudden onset of sore
throat, fever, chills, and vomiting for 5 days. Her surgical,
medical, family, and gynecologic history was noncontributory.
At that time, transvaginal sonography revealed an intrauterine
pregnancy of 9 weeks. Influenza A&B tests (immunochroma-
tographic assay, Sancordon Inc., Taipei, Taiwan) showed
negative results, and the patient was given antipyretic drugs withcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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cough and general malaise. On physical examination, she
appeared acutely ill with tachycardia of 110 beats/min and
a body temperature of 39C. Multiple painful herpetic vesicles
were found over the bilateral vulva with swelling and tender-
ness. Chest radiography revealed no pulmonary infiltration. On
admission, laboratory tests showed a white blood cell count of
2400/mL, with neutrophils 56% and band forms 14%, platelet
104,000/mL (reference: 150e450/mL), D-dimer (fibrin-
degraded products) 1891 mg/L (reference: <324 mg/L), lactate
dehydrogenase 1663 IU/L (reference: 180e460 IU/L), aspartate
aminotransferase (AST) 323 IU/L, alanine aminotransferase
(ALT) 254 IU/L, and C-reactive protein 9.28 mg/dL. The test for
human simplex virus II immunoglobulin M (IgM) was positive
(2.64 RU/mL), on the day of admission, and the influenza A&B
test was positive for influenza A in the nasal and throat samples.
The diagnosis included early pregnancy with H1N1 infection,
vulvar herpes infection, and impending intravascular dissemi-
nated coagulopathy. The patient was transferred to our intensive
care unit (ICU). Oseltamivir (Tamiflu) 75 mg and valacyclovir
500 mg were then administered orally twice daily for 5 days.
The patient’s fever, chills, and vomiting subsided 2 days later. In
the follow up, the real-time reverse-transcriptase polymerase
chain reaction (RT-PCR) analysis of nasal discharge for influ-
enza virus types A&B showed positive results for the H1N1
influenza virus. The early pregnancy was terminated by thera-
peutic curettage at the patient’s request. The surgical specimen
revealed products of conception with the presence of necrotic
chorionic villi, and focal lymphocytes in the decidual tissue
(Fig. 1). No evidence of a pyogenic pathogen was observed; RT-
PCR analysis of gestational tissue for H1N1 was also negative.
Discussion
In April 2009, a novel influenza A (H1N1) virus was
identified, and it has since been recognized as the cause ofFig. 1. Pathological microscopic description of the products of curettage. Sections th
DB ¼ decidual basalis; EG ¼ endometrial glands, long white arrow, two white
NCV ¼ necrotic chorionic villi; VV ¼ viable villi, two black arrows.a pandemic outbreak in the United States and worldwide.
Pandemic H1N1 influenza is having far-reaching effects with
a wide spectrum of disease presentations. Influenza-like illness
is defined as fever and cough or sore throat. Other common
symptoms include rhinorrhea, headache, shortness of breath,
and myalgia, with some patients also reporting vomiting and
diarrhea. In most cases, the reported symptoms are mild.
However, a case of influenza may rapidly worsen.
Because pregnancy suppresses the immune system, women
at any stage of pregnancy are more susceptible to respiratory
infection or adverse alteration of their clinical course [3]. The
susceptibility of pregnant women to viral infections lies in the
fact that pregnancy is associated with an immunologic shift
from cell-mediated immunity to humoral immunity. Although
this physiological change is necessary to facilitate paternally-
derived fetal antigens, it renders the pregnant woman more
vulnerable to intracellular pathogens such as viruses. Simi-
larly, a study by Mullooly and colleagues also attests to the
potential for increased morbidity resulting from influenza in
pregnancy. Looking at influenza A epidemics over a 5-year
period (1975e1979), they found a significant excess of acute
respiratory diseases among pregnant women [4]. Pregnant
women might thus be at increased risk of complications from
pandemic H1N1 virus infection, and illness may progress
rapidly.
One of the more well-studied adverse effects of influenza is
its associated hyperthermia [5]. Studies have shown that
maternal hyperthermia during the first trimester doubles the
risk of neural tube defects and may be associated with other
birth defects and adverse outcomes. In this case, the patient
seemed to benefit from antiviral therapy. A surgical specimen
revealed necrosis of the chorionic villi, which may have been
an ominous sign for her pregnancy.
Importantly, some investigators have found that the time of
initiation of antiviral treatment was an important factor
affecting outcomes. One study reported that women who didrough (A) junction of chorion and (B) decidual basalis at 9 weeks of gestation.
short arrows; FLI ¼ focal lymphocytic infiltration; IS ¼ intervillous space;
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were more likely to require admission to the intensive care
unit and were more likely to die. Similarly, our patient was
admitted to the intensive care unit because she had symptoms
for 5 days.
In our daily practice, there should be suspicion of H1N1
when any pregnant woman complains of upper respiratory
symptoms and/or fever, myalgia, headache, vomiting, or
diarrhea, given the wide spectrum of the disease. Clinical
assessment should include serial monitoring of vital signs,
along with pulse oximetry, and a thorough physical exam. If
symptoms persist, chest radiography and blood gas analysis
should be done. It is also important to note that the sensitivity
of the rapid influenza antigen was as low as 30%, with
a specificity as low as 58% in some studies [6e8], so a nega-
tive test result in the face of strong clinical suspicion should
not alter management. For presumed cases, treatment with
oseltamivir should be initiated within 48 hours of symptom
onset [9]. Treatment may be started beyond 48 hours on
a case-by-case basis [10].
In the present case, the histopathologic report of the
curettage specimen demonstrated necrotic chorionic villi and
focal lymphocytes in the decidual tissue. Actually, we
hypothesized that the necrotic tissue might have represented
an impending missed abortion due to H1N1 infection. In
addition, elevated expression of activation markers by endo-
metrial lymphocyte cells could lead to the initiation of
abnormal immunological reactions capable of destroying the
delicate balance that exists in the immunologically distinct
uterine microenvironment, culminating in fetal rejection [11].
Given the potential for rapidly worsening disease, close
follow up is recommended. The physician who prescribestreatment should evaluate the response to treatment within the
first 24 hours of therapy.
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